Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Kaleebu

Showing results (31-40 of 45) with videos related to

Pageof 5
Sort By:
The Journal of Infectious Diseases|August 1, 1993
Identification of human immunodeficiency virus type 1 subtypes and their distribution in the Commonwealth of Independent States (Former Soviet Union) by serologic V3 peptide-binding assays and V3 sequence analysisR Cheingsong-Popov, A Bobkov, M M Garaev, et al.
HIV Medicine|August 22, 2019
Lack of effectiveness of adherence counselling in reversing virological failure among patients on long-term antiretroviral therapy in rural UgandaJ Birungi, Z Cui, S Okoboi, et al.
AIDS (London, England)|March 10, 2001
HIV-1-related pleural tuberculosis: elevated production of IFN-gamma, but failure of immunity to Mycobacterium tuberculosisW S Hodsdon, H Luzze, T J Hurst, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|March 27, 1999
The immune response to Mycobacterium tuberculosis in HIV-infected and uninfected adults in Uganda: application of a whole blood cytokine assay in an epidemiological studyA M Elliott, T J Hurst, M N Balyeku, et al.
The Journal of Antimicrobial Chemotherapy|March 18, 2014
Phenotypic and genotypic analyses to guide selection of reverse transcriptase inhibitors in second-line HIV therapy following extended virological failure in UgandaR L Goodall, D T Dunn, T Pattery, et al.
Scientific Reports|January 11, 2022
Expression of type I interferon-associated genes at antiretroviral therapy interruption predicts HIV virological reboundP Zacharopoulou, E Marchi, A Ogbe, et al.
Journal of Clinical Microbiology|May 30, 2014
Field study of dried blood spot specimens for HIV-1 drug resistance genotypingC M Parry, N Parkin, K Diallo, et al.
The Journal of Infectious Diseases|March 28, 2003
Immunogenicity of a recombinant human immunodeficiency virus (HIV)-canarypox vaccine in HIV-seronegative Ugandan volunteers: results of the HIV Network for Prevention Trials 007 Vaccine StudyH Cao, P Kaleebu, D Hom, et al.
Journal of Virology|August 6, 2010
Adenovirus-based vaccines: comparison of vectors from three species of adenoviridaeH Chen, Z Q Xiang, Y Li, et al.
Trials|October 30, 2020
Combined HIV Adolescent Prevention Study (CHAPS): comparison of HIV pre-exposure prophylaxis regimens for adolescents in sub-Saharan Africa-study protocol for a mixed-methods study including a randomised controlled trialS Nash, J Dietrich, A S Ssemata, et al.
Pageof 5

Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
The Journal of Infectious Diseases|August 1, 1993
Identification of human immunodeficiency virus type 1 subtypes and their distribution in the Commonwealth of Independent States (Former Soviet Union) by serologic V3 peptide-binding assays and V3 sequence analysisR Cheingsong-Popov, A Bobkov, M M Garaev, et al.
HIV Medicine|August 22, 2019
Lack of effectiveness of adherence counselling in reversing virological failure among patients on long-term antiretroviral therapy in rural UgandaJ Birungi, Z Cui, S Okoboi, et al.
AIDS (London, England)|March 10, 2001
HIV-1-related pleural tuberculosis: elevated production of IFN-gamma, but failure of immunity to Mycobacterium tuberculosisW S Hodsdon, H Luzze, T J Hurst, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|March 27, 1999
The immune response to Mycobacterium tuberculosis in HIV-infected and uninfected adults in Uganda: application of a whole blood cytokine assay in an epidemiological studyA M Elliott, T J Hurst, M N Balyeku, et al.
The Journal of Antimicrobial Chemotherapy|March 18, 2014
Phenotypic and genotypic analyses to guide selection of reverse transcriptase inhibitors in second-line HIV therapy following extended virological failure in UgandaR L Goodall, D T Dunn, T Pattery, et al.
Scientific Reports|January 11, 2022
Expression of type I interferon-associated genes at antiretroviral therapy interruption predicts HIV virological reboundP Zacharopoulou, E Marchi, A Ogbe, et al.
Journal of Clinical Microbiology|May 30, 2014
Field study of dried blood spot specimens for HIV-1 drug resistance genotypingC M Parry, N Parkin, K Diallo, et al.
The Journal of Infectious Diseases|March 28, 2003
Immunogenicity of a recombinant human immunodeficiency virus (HIV)-canarypox vaccine in HIV-seronegative Ugandan volunteers: results of the HIV Network for Prevention Trials 007 Vaccine StudyH Cao, P Kaleebu, D Hom, et al.
Journal of Virology|August 6, 2010
Adenovirus-based vaccines: comparison of vectors from three species of adenoviridaeH Chen, Z Q Xiang, Y Li, et al.
Trials|October 30, 2020
Combined HIV Adolescent Prevention Study (CHAPS): comparison of HIV pre-exposure prophylaxis regimens for adolescents in sub-Saharan Africa-study protocol for a mixed-methods study including a randomised controlled trialS Nash, J Dietrich, A S Ssemata, et al.
Pageof 5